1. Home
  2. SUPN vs CAKE Comparison

SUPN vs CAKE Comparison

Compare SUPN & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • CAKE
  • Stock Information
  • Founded
  • SUPN 2005
  • CAKE 1972
  • Country
  • SUPN United States
  • CAKE United States
  • Employees
  • SUPN N/A
  • CAKE N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • CAKE Restaurants
  • Sector
  • SUPN Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • SUPN Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • SUPN 1.9B
  • CAKE 2.8B
  • IPO Year
  • SUPN 2012
  • CAKE 1992
  • Fundamental
  • Price
  • SUPN $31.70
  • CAKE $65.70
  • Analyst Decision
  • SUPN Hold
  • CAKE Hold
  • Analyst Count
  • SUPN 2
  • CAKE 14
  • Target Price
  • SUPN $36.00
  • CAKE $53.50
  • AVG Volume (30 Days)
  • SUPN 685.5K
  • CAKE 1.4M
  • Earning Date
  • SUPN 08-05-2025
  • CAKE 07-30-2025
  • Dividend Yield
  • SUPN N/A
  • CAKE 1.64%
  • EPS Growth
  • SUPN N/A
  • CAKE 45.67
  • EPS
  • SUPN 1.11
  • CAKE 3.19
  • Revenue
  • SUPN $667,997,000.00
  • CAKE $3,617,673,000.00
  • Revenue This Year
  • SUPN N/A
  • CAKE $7.04
  • Revenue Next Year
  • SUPN $12.02
  • CAKE $6.10
  • P/E Ratio
  • SUPN $28.89
  • CAKE $20.61
  • Revenue Growth
  • SUPN 11.82
  • CAKE 4.42
  • 52 Week Low
  • SUPN $25.55
  • CAKE $33.50
  • 52 Week High
  • SUPN $40.28
  • CAKE $65.99
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 48.95
  • CAKE 78.81
  • Support Level
  • SUPN $30.93
  • CAKE $59.16
  • Resistance Level
  • SUPN $32.78
  • CAKE $61.21
  • Average True Range (ATR)
  • SUPN 1.00
  • CAKE 1.73
  • MACD
  • SUPN -0.03
  • CAKE 0.44
  • Stochastic Oscillator
  • SUPN 46.56
  • CAKE 96.98

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: